Author

Meena Chakraborty

Stanford Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Aaron D. GitleriD· 1 shared Caitlin M. RodrigueziD· 1 shared Eduardo Tassoni-TsuchidaiD· 1 shared Garam KımiD· 1 shared Jacob A. BlumiD· 1 shared Julien CouthouisiD· 1 shared Lisa NakayamaiD· 1 shared Michael Cory BassikiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Aaron D. GitlerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Small molecule v-ATPase inhibitor Etidronate lowers levels of ALS protein ataxin-2

Garam Kım, Lisa Nakayama, Jacob A. Blum, Tetsuya Akiyama, Steven Boeynaems, Meena Chakraborty, Julien Couthouis, Eduardo Tassoni-Tsuchida, Caitlin M. Rodriguez, Michael Cory Bassik, Aaron D. Gitler

The paper identifies Etidronate, an FDA-approved drug, as a method to lower ataxin-2 levels in neurons using a CRISPR screen and validates its efficacy in mice.

bioRxiv · Dec 20, 2021 · PreprintNeuroscience